Remimazolam for safer sedation during egg retrieval
Part of Women’s health & pregnancy clinical trials.
This trial tests if remimazolam, a sedative, can reduce low oxygen levels during a procedure to collect eggs from the ovaries. It may be a safer option for people having this fertility treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You are scheduled for a painless egg retrieval procedure
- You are in good overall health (ASA class I or II)
- You do not have serious heart, lung, liver, or kidney problems
- You do not have a history of alcohol abuse
- You are not allergic to sedatives like benzodiazepines or propofol
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study tests a sedative called remimazolam to see how well it works and how safe it is for women having gynecologic surgery. It aims to find the best way to keep patients comfortable and stable during the procedure.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This trial tests a sedative called remimazolam for people with serious health conditions who need an ERCP, a procedure to examine the bile ducts. It aims to find a safer sedation option for those at higher risk.
This trial tests a newer anesthetic drug, remimazolam, during heart surgery that uses a heart-lung machine. It aims to see if it is safe and works well for patients having this type of surgery.
Hear when a new Hypoxia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.